Bayer ( (DE:BAYN) ) has issued an announcement.
Bayer Aktiengesellschaft announced a transaction involving the purchase of shares by the Hebert-Schechter Trust, associated with Lori Schechter, a member of the company’s supervisory body. This transaction, executed on March 7, 2025, at a price of 23.37 EUR per share, reflects the commitment of Bayer’s supervisory board members to invest in the company, potentially signaling confidence in Bayer’s strategic direction and future performance.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of health care and agriculture. The company is known for its pharmaceutical products, consumer health products, and agricultural solutions, focusing on improving people’s quality of life and contributing to sustainable agriculture.
YTD Price Performance: 21.40%
Average Trading Volume: 754,296
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €22.84B
For detailed information about BAYN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com